Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
8.41
+0.36 (4.47%)
At close: Jun 27, 2025, 4:00 PM
8.50
+0.09 (1.07%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Teladoc Health Revenue
Teladoc Health had revenue of $629.37M in the quarter ending March 31, 2025, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $2.55B, down -2.54% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.55B
Revenue Growth
-2.54%
P/S Ratio
0.47
Revenue / Employee
$464,148
Employees
5,500
Market Cap
1.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TDOC News
- 4 days ago - Here's why Teladoc Health stock price could surge 95% - Invezz
- 16 days ago - Teladoc Health, Inc. (TDOC) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 23 days ago - Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewsWire
- 24 days ago - Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewsWire
- 6 weeks ago - Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure - Benzinga
- 7 weeks ago - Teladoc Health: No Real Rescue In Sight - Seeking Alpha
- 2 months ago - Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Teladoc Health Reports First Quarter 2025 Results - GlobeNewsWire